In addition, regarding to the highly significant improvement in OS for patients with brain metastases, this combination may be preferred in this subgroup.
← all excerpts
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi.
1
—
—